Invention Grant
- Patent Title: Dengue serotype 2 attenuated strain
- Patent Title (中): 登革热血清型2减毒株
-
Application No.: US13281255Application Date: 2011-10-25
-
Publication No.: US08795688B2Publication Date: 2014-08-05
- Inventor: Richard Kinney , Claire Y. H. Kinney , Véronique Barban , Jean Lang , Bruno Guy
- Applicant: Richard Kinney , Claire Y. H. Kinney , Véronique Barban , Jean Lang , Bruno Guy
- Applicant Address: FR Lyons US GA Atlanta
- Assignee: Sanofi Pasteur,Centers for Disease Control and Prevention
- Current Assignee: Sanofi Pasteur,Centers for Disease Control and Prevention
- Current Assignee Address: FR Lyons US GA Atlanta
- Agency: Clark & Elbing LLP
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C12N7/00 ; C12N7/08
Abstract:
The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain.
Public/Granted literature
- US20120083585A1 DENGUE SEROTYPE 2 ATTENUATED STRAIN Public/Granted day:2012-04-05
Information query
